AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
_6ff029a61766633234293.png?format=webp&width=1186&height=250)
Siemens Healthineers in Talks for $7 Billion Diagnostics Unit Sale
ByAinvest
Wednesday, Sep 10, 2025 9:20 am ET1min read
Siemens Healthineers is reportedly in early talks with private-equity firms Blackstone, CVC Capital Partners, and KKR to sell its diagnostics unit, potentially valued at over 6 billion euros ($7.03 billion). Representatives for the companies declined to comment.
Siemens Healthineers AG, a German healthcare technology company, is reportedly in early discussions with private equity firms Blackstone Inc., CVC Capital Partners Plc, and KKR & Co. about a potential sale of its diagnostics segment. The talks, which are part of the company's efforts to streamline operations, have sparked interest among investors.The diagnostics unit, which tests samples of blood and tissue to identify diseases and infections, could be valued at more than €6 billion ($7 billion), according to sources familiar with the matter. The imaging division and the Varian unit, which focuses on cancer-care technologies, are not part of the sale discussions [^1, 2, 3, 4].
Shares of Siemens Healthineers saw a significant uptick on Wednesday, climbing as much as 3.6 percent and approaching their 200-day moving average. The rally was fueled by the Bloomberg News report suggesting preliminary talks regarding the diagnostics division sale [3].
The company has been reviewing its diagnostics business for over two years, and the current discussions are in the early stages. There is no certainty that these preliminary deliberations will lead to a transaction, and Siemens Healthineers could decide to keep the business [4].
Siemens Healthineers will hold its capital markets day on November 17, where it usually outlines its business strategy and targets. The company's largest shareholder is German engineering group Siemens AG, which holds a stake of approximately 71 percent [4].
Representatives for Siemens Healthineers, Blackstone, CVC, KKR, and Montagu have declined to comment on the matter.
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet